Krista Sauls

Krista Sauls is a Senior Director at Daiichi Sankyo, Inc., focusing on Functional Excellence and Alliance Management since October 2022. Prior to this role, Krista served as Senior Director of Operational Excellence and Clinical Quality at Editas Medicine from September 2020 to October 2022. Krista's extensive background includes a nearly two-decade tenure at Celgene, where various roles encompassed Head of Clinical Trial Risk Management for Early Development, Director of Clinical Science Operations in Hematology/Oncology, and several positions in clinical research operations. Krista's career began at Ingenix (now i3 Research) as a Clinical Study Coordinator. Krista holds a Bachelor of Science in Health Science from Kaplan University, completed in 2011.